Regulation 32 Statement - Half Year ended 31st March 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Chemarkart India Ltd, listed on BSE (Scrip Code: 544442), has filed its half-yearly statement under SEBI Regulation 32 confirming no deviations in the use of IPO proceeds. The company raised Rs. 64.48 Crores via IPO on 9th July 2025, with Rs. 9.80 Crores in issue expenses leaving Rs. 54.68 Crores in net proceeds to be utilized. Of this, Rs. 34.11 Crores has been utilized so far, with Rs. 30.37 Crores remaining unutilized. The largest allocation of Rs. 34.68 Crores is for financing a manufacturing facility through a wholly-owned subsidiary, Easy Raw Materials Private Limited, of which only Rs. 4.57 Crores (13%) has been deployed so far. Repayment of borrowings (Rs. 20 Crores) and General Corporate Purpose (Rs. 9.80 Crores) have been nearly fully utilized. The Audit Committee and statutory auditor (Bagaria & Co LLP) have confirmed nil comments and certified proper utilization per the offer document.
The filing is positive for shareholders as it confirms strict adherence to IPO fund utilization as stated in the prospectus, with no deviation reported. The large unutilized balance (Rs. 30.37 Crores) for the manufacturing facility will be deployed over time, and investors can monitor progress through future monitoring agency reports.